Skip to main content

Table 1 Summary of clinical findings for epilepsy patients and controls

From: Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions

Pathology type

Number of cases

Gender (males/females)

Mean age at surgery (years/range)

Localization

Mean duration of epilepsy (years/range)

FCD I

6

3/3

27.8 (19 to 39)

4 Temporal

7.7 (6 to 13)

2 Frontal

FCD IIa

6

3/3

24.3 (11 to 24)

3 Frontal

6.1 (2 to 11)

3 Temporal

FCD IIb

15

7/8

23.2 (17 to 41)

8 Temporal

7.8 (3 to 15)

7 Frontal

Cortical tubers (TSC)

6

3/3

17.8 (5 to 35)

3 Frontal

13.5 (2.8 to 34)

3 Temporal

2 Parietal

GG

15

8/7

29.2 (15 to 46)

Temporal

7.8 (3 to 15)

Controls (no epilepsy)

6

3/3

30.1 (20 to 41)

Temporal

-

  1. FCD, focal cortical dysplasia; TSC, tuberous sclerosis complex; GG, ganglioglioma.